Globus Medical (GMED) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Globus Medical (GMED) is Neutral.

The composite score behind that read is -0.10, weighing +0.11 of bullish evidence against -0.32 bearish.

Globus Medical last closed at $74.65, +1.80% on the session.

Against the IVW growth benchmark the position is +1.00% over the forecast window.

The read is built from 15 underlying insights — 2 bullish and 13 bearish.

Agreement across those insights is 87%.

19 graded predictions for GMED so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Globus Medical in the 51st percentile on valuation and the 65th percentile on return on equity, where 100 is best.

Globus Medical is classified under Health Care / Health Care Equipment & Supplies, with a market capitalisation of $9.85B.

StockMap tracks Globus Medical as the 23rd largest of the 140 companies it covers in the Health Care Equipment & Supplies industry, part of the Health Care sector.

Across that group the current two-week reads are 122 Neutral, 16 Moderate Underperform and 2 Moderate Outperform.

On that composite Globus Medical ranks 93rd of 140 in the group, against a group median of -0.03.